Headache patients in primary care and a tertiary care unit in Zürich, Switzerland

Cephalalgia

Volumn 26, Issue 12, 2006, Pages 1451-1457

  Gantenbein, A R ^a   Kozak, S ^a   Agosti, F ^b   Agosti, R ^c   Isler, H ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Hirslanden Clinic ^*

^c KLINIK HIRSLANDEN   (Switzerland)

Author keywords

Chronic headache; Continuing medical education; Drug treatment; Primary care; Primary headaches; Tertiary care

Indexed keywords

ANALGESIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIHYDROERGOTAMINE; ERGOTAMINE; MAGNESIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; TIZANIDINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; GENERAL PRACTITIONER; HEADACHE; HUMAN; MALE; MEDICAL PRACTICE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; SWITZERLAND; TERTIARY HEALTH CARE;

DEMOGRAPHY; FEMALE; HEADACHE; HUMANS; MALE; MIDDLE AGED; PAIN CLINICS; PRIMARY HEALTH CARE; SWITZERLAND;

EID: 33751183949     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2006.01225.x     Document Type: Article

References (21)

1. Kozak S, Gantenbein AR, Isler H, Merikangas KR, Angst J, Gamma A et al. Nosology and treatment of primary headache in a Swiss headache clinic. J Headache Pain 2005; 6:121-7.
2. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl. 7):1-96.
3. Goadsby PJ, Boes C. Chronic daily headache. J Neurol Neurosurg Psychiatry 2002; 72 (Suppl. 2):ii2-ii5.
4. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004;24 (Suppl. 1):9-160.
5. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol 1991; 44:1147-57.
6. Gesztelyi G, Bereczki D. Primary headaches in an outpatient neurology headache clinic in East Hungary. Eur J Neurol 2004; 11:389-95.
7. Bundesamt für Statistik. Bundesamt für Statistik - Bevölkerung. Available at http://www.bfs.admin.ch/bfs/portal/de/index/ themen/bevoelkerung.html 2000. Last accessed: 2000.
8. Waters WE. Migraine: intelligence, social class, and familial prevalence. BMJ 1971; 2 (753):77-81.
9. Statistisches Amt des Kantons Zürich. Bevölkerungsprognosen: Resultate. Available at http://www.statistik.zh.ch/produkte/bevprog/ 2005. Last accessed: 2004.
10. Bigal ME, Lipton RB, Tepper SJ, Rapoport AM, Sheftell FD. Primary chronic daily headache and its subtypes in adolescents and adults. Neurology 2004; 63:843-7.
11. Bigal ME, Sheftell FD, Rapoport AM, Lipton RB, Tepper SJ. Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache. Cephalalgia 2002; 22:432-8.
12. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003; 43:179-90.
13. Winnem M, Eskerud J, Monstad I, Kierulf H, Aasen J, Skovlund E. Diagnosis of migraine in general practice. Tidsskr Nor Laegeforen 1993; 113:2386-8.
14. Cassidy EM, Tomkins E, Hardiman O, O'Keane V. Factors associated with burden of primary headache in a specialty clinic. Headache 2003; 43:638-44.
15. Evers S, Suhr B, Bauer B, Grotemeyer KH, Husstedt IW. A retrospective long-term analysis of the epidemiology and features of drug-induced headache. J Neurol 1999;246:802-9.
16. Magee R. Saint Anthony's fire revisited. Vascular problems associated with migraine medication. Med J Aust 1991; 154:145-9.
17. Schoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia 1994; 14:328-9.
18. Diener HC, Kaube H, Limmroth V. Antimigraine drugs. J Neurol 1999; 246:515-9.
19. Saper JR, Winner PK, Lake AE 3rd. An open-label dosetitration study of the efficacy and tolerability of tizanidine hydrochloride tablets in the prophylaxis of chronic daily headache. Headache 2001; 41:357-68.
20. Sandor PS, Afra J. Nonpharmacologic treatment of migraine. Curr Pain Headache Rep 2005; 9:202-5.
21. Biondi DM. Physical treatments for headache: a structured review. Headache 2005; 45:738-46.